55 related articles for article (PubMed ID: 28164488)
21. Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer.
Shuster H; Funkhouser A; Allen L; Heo M; Martin JC; Edenfield WJ; Blenda AV
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539500
[TBL] [Abstract][Full Text] [Related]
22. Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
Horiguchi H; Kadomatsu T; Yamashita T; Yumoto S; Horino T; Sato M; Terada K; Miyata K; Ichigozaki Y; Kimura T; Fukushima S; Moroishi T; Oike Y
Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38467764
[TBL] [Abstract][Full Text] [Related]
23. Angptl2 is a Marker of Cellular Senescence: The Physiological and Pathophysiological Impact of Angptl2-Related Senescence.
Thorin-Trescases N; Labbé P; Mury P; Lambert M; Thorin E
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830112
[TBL] [Abstract][Full Text] [Related]
24. Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update.
Zhang H; Liu M; Wang X; Ren Y; Kim YM; Wang X; Lu X; Pang H; Liu G; Gu Y; Sun M; Shi Y; Zhang C; Zhang Y; Zhang J; Li S; Zhang L
Front Genet; 2021; 12():697009. PubMed ID: 34447409
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
Wei X; Nie S; Liu H; Sun J; Liu J; Li J; Li S; Wang S; Han S; Wang J; Sun Y
Am J Cancer Res; 2017; 7(11):2220-2233. PubMed ID: 29218246
[TBL] [Abstract][Full Text] [Related]
26. High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation.
Thorin-Trescases N; Thorin E
Oxid Med Cell Longev; 2017; 2017():1096385. PubMed ID: 29138671
[TBL] [Abstract][Full Text] [Related]
27. Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT.
Deng Y; Zhao H; Zhou J; Yan L; Wang G;
BMC Infect Dis; 2017 Sep; 17(1):650. PubMed ID: 28962551
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic indicators in stage I non-small cell lung cancer].
Barlési F; Doddoli C; Greillier L; Astoul P; Giudicelli R; Fuentes P; Thomas P
Rev Mal Respir; 2004 Feb; 21(1):93-103. PubMed ID: 15260042
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
[TBL] [Abstract][Full Text] [Related]
32. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
34. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
